GOMEKLI is the first and only medicine approved for both adults and children with NF1-PN –– Approval based on positive data ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

Option activity in these three fallen angel stocks has ticked up lately, and the shares could be ready to follow along for ...

Pharmacy spend will rise 3.8%, driven in part by increased demand for specialty medications ... The healthcare industry will also see cost increases related to supply chain pressures, according to ...

India's pharmaceutical exports are projected to double from approximately $27 billion in 2023 to reach $65 billion by 2030, a ...

As a specialty pharmacy, the number one priority is getting the therapy to the patient as soon as possible so they can begin their treatment. In most cases, the pharmacy is trying to get that ...

Managing rising pharmaceutical costs, particularly those related to ... a large portion of specialty pharmaceutical spending, according to Steven Lucio, senior principal of pharmacy solutions ...

Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular medications like Ozempic and Wegovy.

Healthcare startup Capital Rx seeing revenue surge as Congress seeks to regulate the PBM giants that profit from high drug ...

The two have mended fences after a nasty contract dispute in 2022 caused Kroger pharmacies to go out of network with Express ...

Amazon Pharmacy's RxPass program shows promise in boosting medication adherence and reducing costs, according to a study. Amazon Pharmacy's RxPass, a subscription program offering Amazon Prime ...